Antidepressant Deck 3 Flashcards

1
Q

Treatment principles

A

Goals
Strategic and tactical decision making
patient counseling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Strategic and Tactical Decision-Making

A

Patient factors
Disease Factors
Drug Factors
Optimum Plan

“The whether and what”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

You don’t want to treat to ____ you want to treat to __

A

response

remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initiation

A

Targeted Therapy
Dosing
Frequent Monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antidepressent most side effects are worse within

A

the first couple of weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Targeted therpay

A

y Patient factors
y Drug factors
y Disease Factors/Co-morbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Frequent Monitoring

A

y Weekly-biweekly
y Suicide risk
y Adverse effects
y Expected outcome/Effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Titration: Med change every

A

3-14* days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

you want to get to a

A

therapeutic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If no response and you are at a maximum dose at 8 to 12 weeks

A
y Change to different class or change to different med w/in same
class if no response after 8-12 weeks of maximum dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oher options if you are at a maxium dose

A

add a second agent

refer to psych consultation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Follow up:

A

every 1-2 weeks for 6-8 weeks in initiation;

every 2 months for severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Use _____ to monitor symptoms

A

clinical tools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Usual course of treatment

A

Major depression: 6-9 months*

Long term treatment may be needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Common causes of treatment failure

A

y Inadequate dose or duration of treatment
y Prominent side effects
y Non-compliance
y Incorrect diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Plasma levels: when to use

A

y Failure to respond/use of higher than usual doses
y Impaired physical status
y S/E evaluation and/or overdose

17
Q

Partial response: consider

A

augmentation

18
Q

Factors to consider with augmentation

A

Efficacy, tolerability, side effect burden, drug interactions, dosing
convenience, adherence, cost

19
Q

You want to add an agent from

A
Add agent from a different class
y Wellbutrin, BuSpar (most commonly added)
20
Q

Examples of other agents

A
y Anxiolytics
y Antipsychotics and mood stabilizers
y Psychostimulants
y DHEA
y Triiodothyronine (T3)
y Ketamine?
21
Q

What is not recommended due to interaction with SSRI

A

St. john’s wart - significant. Increases effects of SSRI

22
Q

Withdraw medication

A

slowly. 2 to 4 week taper

23
Q

Taper method

A

decreasing dose, then every other day, or a half a dose at a time. Depends on the indvidual

24
Q

RCT: no difference in

A

no difference in symptoms between 3 day and 14 day

taper - anecdotally not Mary’s experience

25
Q

Monitor what during withdrawl period

A

mood

26
Q

review what during taper

A

relapse criteia

27
Q

consider what during taper

A

seasonal and situational data

28
Q

SSRI/SNRI disconintuation syndrome in adults acronym

A

FINISH

29
Q

F

A

Flu like symptoms: fatigue, H/A, myalgias, diarrhea

30
Q

I

A

Insomnia: vivid or disturbing dreams

31
Q

N

A

Nausea

32
Q

I

A

Imbalance: gait instability dizziness vertigo mbalance: gait instability, dizziness, vertigo

33
Q

S

A

Sensory imbalance: paresthesia, “electric shock” sensation,

visual disturbances

34
Q

H

A

Hyperarousal: anxiety, agitation

35
Q

Onset and resolution of FINISH

A

Onset: 24-72h + resolution:1-14 days

36
Q

Incidence of Finish

A

Incidence: 20-40% (treated at least 6wks)

37
Q

Serotonin Syndrome S/S

A
y Signs and Symptoms
y CNS and neuromuscular
y Autonomic instability
y GI: nausea, diarrhea
y Onset: often rapid (minutes); may be life threatening
38
Q

Serotonin Syndrome treatment

A

y Stop medication
y Benzodiazepines for agitation, hyperreflexia
y Treat individual symptoms (depends on severity)